STING1 and metabolic dysfunction-associated steatotic liver disease: The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway was recently identified as a key factor in liver disorders [80], including HBV infection [81], HCV infection [82], and NAFLD [83].